Elevated peritoneal expression and estrogen regulation of nociceptive ion channels in endometriosis by Greaves, Erin et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elevated peritoneal expression and estrogen regulation of
nociceptive ion channels in endometriosis
Citation for published version:
Greaves, E, Grieve, K, Horne, AW & Saunders, PT 2014, 'Elevated peritoneal expression and estrogen
regulation of nociceptive ion channels in endometriosis' Journal of Clinical Endocrinology & Metabolism, vol.
99, no. 9, pp. jc20142282. DOI: 10.1210/jc.2014-2282
Digital Object Identifier (DOI):
10.1210/jc.2014-2282
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Clinical Endocrinology & Metabolism
Publisher Rights Statement:
Copyright © 2014 by the Endocrine Society
This article has been published under the terms of the Creative Commons Attribution License (CC-BY), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited. Copyright for this article is retained by the author(s). Author(s) grant(s) the Endocrine Society the
exclusive right to publish the article and identify itself as the original publisher.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Elevated Peritoneal Expression and Estrogen
Regulation of Nociceptive Ion Channels in
Endometriosis
Erin Greaves, Kelsey Grieve, Andrew W. Horne, and Philippa T. K. Saunders
Medical Research Council Centre for Reproductive Health, The University of Edinburgh, Queens Medical
Research Institute, Edinburgh EH16 4TJ, United Kingdom
Context:Ovarian suppression is a common treatment for endometriosis-associated pelvic pain. Its
exact mechanism of action is poorly understood, although it is assumed to reflect reduced pro-
duction/action of estrogens.
Objective: The objective of the study was to measure the expression of mRNAs encoded by noci-
ceptive genes in the peritoneum of women with chronic pelvic pain (CPP) with or without endo-
metriosis and to investigatewhether estrogensalternociceptivegeneexpression inhuman sensory
neurons.
Design: The study was performed using human tissue analysis and cell culture.
Setting: The study was conducted at a university research institute.
Patients: Peritoneal biopsieswereobtained fromwomenwithCPP andendometriosis (n 12), CPP
and no endometriosis (n  10), and no pain or endometriosis (n  5). Endometriosis lesions were
obtained from women with endometriosis (n  18).
Main OutcomeMeasures:mRNAs encoding ion channels (P2RX3, SCN9A, SCN11A, TRPA1, TRPV1)
and the neurotransmitter TAC1weremeasured in human tissue samples and in human embryonic
stem cell-derived sensory neurons treated with estrogens.
Results: TRPV1, TRPA1, and SCN11A mRNAs were significantly higher in the peritoneum from
women with endometriosis (P  .001, P  .01). TRPV1, SCN9A, and TAC1 were elevated in endo-
metriosis lesions (P .05). P2RX3mRNAwas increased in the peritoneumofwomenwith CPP,with
and without endometriosis (P  .05). Incubation of sensory neurons with 17-estradiol increased
TRPV1 mRNA (P  .01). The estrogen receptor--selective agonist 2,3-bis(4-hydroxy-phenyl)-pro-
pionitrile increased concentrations of TRPV1, P2RX3, SCN9A, and TAC1 mRNAs.
Conclusions:Estrogen-dependentexpressionofTRPV1 in sensoryneuronsmayexplainwhyovarian
suppression can reduce endometriosis-associated pain. Strategies directly targeting ion channels
may offer an alternative option for the management of CPP. (J Clin Endocrinol Metab 99:
E1738–E1743, 2014)
Endometriosis is associated with debilitating chronicpelvic pain (CPP). It is an estrogen-dependent inflam-
matory disorder characterized by growth of endometrium
(lesions) in ectopic locations, typically on the peritoneum
and ovaries. Lesions become innervated by small diameter
nerve fibers typical of afferent sensory innervation (1), and
stimulation of these nerves by the inflammatory milieu
within a lesion may be a direct cause of endometriosis-
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associated pain. Women with endometriosis often suffer
from cyclical pain, and painmay occur in associationwith
other conditions, such as irritable bowel syndrome and
migraine (2, 3). Visceral, mechanical, and generalized hy-
persensitivity is extremely common in women with endo-
metriosis (4), although there is no correlation between the
extent of disease and reportedpain scores (5). Stratton and
Berkley (6) recently provided an overview of evidence for
recruitment of nerves to endometriosis lesions, and they
suggested that their stimulation and subsequent dialogue
with the central nervous system may explain why women
with endometriosis suffer from chronic pain.
Studies in patients with altered pain responses due to
rare conditions as well as genetically modified mice (7)
have identified key genes expressed by nerves that detect
noxious stimuli (nociceptors). These include the TRP
channel family (TRPA1, TRPV1), sodium voltage-gated
ion channels (SCN9A, SCN11A) and purinergic X (P2X)
receptors. An increase in the expression of neuropeptides,
neurotrophins, and ion channels leading to an increased
responsiveness of nociceptors has been suggested as an
important contributor to development of hypersensitivity
(8). For example, the TRPV1 channel (capsaicin receptor)
has been implicated in development of hypersensitivity to
heat associated with inflammation in chronic pain condi-
tions (9). Recently studies have reported that TRPV1 im-
munoreactivity is increased in the peritoneum of women
withCPP (10) and in lesions ofwomenwith endometriosis
(11). Theneuropeptide substance P (encodedby theTAC1
gene) has been immunolocalized to endometriosis lesions
(12), and TRPA1 has been implicated in thermal and me-
chanical hypersensitivity to pain (13). The purinergic X
family of receptors are voltage-gated ion channels that
open in response to ATP released from cells during in-
flammation and have also been associated with mechan-
ical hyperalgesia (14). Sodium channels are also critical in
producing an acute response to noxious stimuli; Nav1.7
(SCN9A) and Nav1.9 (SCN11A) are both reported to be
increased in a range of inflammatory pain conditions (7).
Notably, induction of a hypoestrogenic state often ame-
liorates CPP, and although the mechanisms responsible
for this remain poorly understood, estrogens are reported
to influence the sensitivity of peripheral sensory neurons
and central neuronal activity in pain states (2).
In this study we measured the concentrations of mR-
NAs encoded by genes known to regulate nociception in
tissue samples fromwomenwithCPP, someofwhomwere
diagnosed with endometriosis. We also explored the im-
pact of estrogens on their expression using a newly estab-
lished in vitro model of human embryonic stem (ES) cell-
derived sensory neurons.
Materials and Methods
Patients and recovery of tissue samples
The study was approved by the Lothian Research Ethics
Committee (LREC 11/AL/0376). Peritoneal biopsies [1.0 
0.5 cm size: stored in RNAlater (Applied Biosystems) at20°C]
were obtained from 3 groups of women (aged 18–45 y) at the
time of surgery with informed consent: 1) women undergoing
laparoscopic investigation for CPP with histological evidence of
pelvic endometriosis (n  12); 2) women undergoing laparo-
scopic investigation for CPP without evidence of endometriosis
(n  10); and 3) women undergoing laparoscopic sterilization
without CPP and without evidence of endometriosis (n  5).
Endometriosis lesions were also collected from women with en-
dometriosis (n  18). Peritoneal biopsies from women without
endometriosiswere recovered froma site prone to endometriosis
(pouch of Douglas) and in women with endometriosis the peri-
toneal biopsy was recovered from a site adjacent to the endo-
metriosis lesion. None of the women had taken exogenous hor-
mones for at least 3 months at the time of sampling.
Differentiation of sensory neurons from human
embryonic stem cells
Human ES cells, strain H9 (WiCell) were cultured on inacti-
vated mouse embryonic fibroblasts maintained in Knockout
DMEM/F12 supplemented with 20% knockout serum replace-
ment (Gibco), 1 mM L-glutamine, 100 MMEM nonessential
amino acids, and 0.1 M -mercaptoethanol, with 6 ng/mL
FGF-2 (R&D Systems). Differentiation of ES cells was induced
usingacocktail of smallmolecule inhibitors asdetailedbyCham-
bers et al (15). RNA was extracted from cells at selected time
points for the characterization andverificationof phenotype.On
day 22 the sensory neurons were trypsinized and reseeded into
12-well plates at equal densities (5105 cells/well).Onday25,
the cells were treated for 24 hours with 108 M 17-estradiol
(E2; Sigma), the estrogen receptor (ER)- selective agonist
4,4,4-[4-propyl-(1H)-pyrazole-1,3,5-tryl] trisphenol (PPT), or
the ER selective agonist 2,3-bis(4-hydroxy-phenyl)-propion-
itrile (DPN; Tocris) alone or in combination with the antiestro-
gen fulvestrant (ICI; 107 M; Tocris) dissolved in dimethylsulf-
oxide (DMSO).
Immunocytochemistry
Expression of neurofilament protein was detected using neu-
rofilament H chicken antineurofilament H (1:1000; Covance);
nuclei were stained with 4,6-diamino-2-phenylindole and im-
ages captured on an Axiovert microscope (Carl Zeiss Inc).
Calcium assay
Neurons were stimulated with 4 nM capsaicin (Sigma), and
intracellular calciumwasmeasured using a calcium indicator kit
(BD Biosciences) with calcium flux captured using a NOVOstar
microplate fluorometer (BMG Labtech).
Quantitative real-time PCR
RNA was extracted from human tissues by homogenization
in TRI reagent, chloroformphase separation and the lysates pro-
cessed using an RNAeasy kit (QIAGEN). RNA was extracted
from cells using RLT (lysis) buffer and an RNAeasy kit. Samples
were deoxyribonuclease treated (QIAGEN) and concentration
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and purity assessed using a NanoDrop ND 1000. cDNA was
synthesized using SuperScript VILO enzyme (Invitrogen) with
100 ng starting template in a 20-L reaction. PCRs (15L)were
performed using the Roche Universal Probe Library (Roche Ap-
plied Science) and Express quantitative PCR supermix (Invitro-
gen) with primers added at a concentration of 20 M and ther-
mal cycling performed on a 7900 Fast real-time PCR machine
(Applied Biosystems) with 18S selected as the reference gene
because we have confirmed this gene is not altered by estrogenic
treatments. cDNA was added at 1.5 L per reaction and dupli-
cate technical replicates performed.
Datawere analyzedwithRQmanager software (AppliedBio-
systems) using the Ctmethod, and sampleswere normalized to
either one laparoscopic sterilization sample (patients) or one ve-
hicle control sample (cells). Primer sequences included the fol-
lowing: TRPA1, forward, 5-tggacaccttcttcttgcatt-3, reverse,
5-tcatccatttcatgcagcac-3; TRPV1, forward, 5-agagtcacgctg-
gcaacc-3, reverse, 5-ggcagagactctccatcacac-3; SCN9A, for-
ward, 5-caacttttaagggatggacga-3, reverse, 5-tcatatttgggctgct-
tgtct-3; SCN11A, forward, 5-acctgagcctgaacaacagg-3,
reverse, 5-tttgaactctctggctcgtg-3; P2RX3, forward, 5-ggcctt-
tacttctgtgggagt-3, reverse, 5-aaacttcttggctttgtactggtc-3;
TAC1, forward, 5-gcctcagcagttctttggat-3, reverse, 5-agcctt-
taacagggccactt-3; ER, forward, 5-ttactgaccaacctggcaga-3,
reverse, 5-atcatggagggtcaaatcca-3; and ER, forward, 5-at-
catggagggtcaaatcca-3, reverse, 5-tgggcattcagcatctcc-3.
Statistical analysis
Quantitative PCR (QPCR) data were analyzed using a one-
way ANOVA and a Newman Keuls post hoc multiple compar-
ison test. Statistics were generated using GraphPad Prism 6
software.
Results
mRNAs encoding nociceptive
proteins exhibit altered
expression patterns in the
peritoneum of women with CPP
Measurement of mRNAs en-
coded by TAC1 and nociceptive ion
channels revealed differences be-
tween tissue samples; TAC1 was el-
evated only in endometriosis lesions
(Figure 1A; P  .05), and P2RX3
was increased in the peritoneum of
women with CPP, regardless of
whether they were diagnosed with
endometriosis compared with the
peritoneum of healthy women (Fig-
ure 1B; P  .05). SCN9A (Nav1.7)
was elevated in lesions from women
with endometriosis (Figure 1C; P 
.05), whereas SCN11A was signifi-
cantly higher in the peritoneum of
women with CPP and endometriosis
compared with the peritoneum of
women with CPP alone (Figure 1D;
P  .001). mRNA encoded by TRPA1 was significantly
increased in the peritoneumofwomenwith endometriosis
compared with the peritoneum of healthy women and
those with CPP alone (Figure 1E; P .001). TRPV1 was
elevated in peritoneum (P .01) and in lesions (P .05)
of women with endometriosis compared with the perito-
neum of healthy women (Figure 1F).
mRNA concentrations of nociceptive genes are
regulated by estrogens in ES cell-derived sensory
neurons
Sensory neurons immunopositive for neurofilament
were generated in vitro (15) (Figure 2, A–C). Differenti-
ation was accompanied by a reduction in octamer tran-
scription factor-4 mRNA concentrations and an increase
in TAC1, SCN9A, and SCN11A (Figure 2D), consistent
with differentiation of sensory neurons with a nociceptor-
like phenotype. When the differentiated cells were incu-
bated with capsaicin (activates TRPV1), an intracellular
calcium flux was detected (Figure 2E). The expression of
ER subtypes changed during differentiation; ERmRNA
concentrations decreased and ER mRNAs increased
(Figure 2F). Stimulation of sensory neurons with the es-
trogen ligands E2, DPN, and PPT revealed ER-dependent
regulation of nociceptive ion channels.TAC1 and P2RX3
mRNAs were increased after the incubation with DPN
compared with cells incubated with DPN in the presence
of ICI (Figure 2G; P  .001) or vehicle control (DMSO;
Figure 1. The neuropeptide TAC1 and nociceptive ion channels are differentially expressed in
CPP and in endometriosis. A–F, mRNA concentrations of the neuropeptide TAC1 (A) and the
nociceptive ion channels P2RX3 (B), SCN9A (C), SCN11A (D), TRPA1 (E), and TRPV1 (F) were
analyzed using QPCR. Concentrations of mRNAs were measured in the peritoneum of women
with no pain (control; n  5), compared with the peritoneum of women with CPP but no
obvious underlying pathology (PP; n  10), and the peritoneum (EP; n  12) and peritoneal
lesions (EL; n  18) of women with confirmed endometriosis. RQ, relative quantification.
Statistical analysis was performed using a one-way ANOVA combined with a Newman Keuls post
hoc test. *, P  .05; **, P  .01; ***, P  .001. Asterisks denote statistical significance
compared with control, and lines and asterisks denote significance between specific groups.
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Figure 2. mRNA concentrations of nociceptive markers are regulated by estrogens in an in vitro model of human sensory neurons with a
nociceptor-like phenotype derived from ES cells. A, Human ES cells were differentiated into sensory neurons with a nociceptor-like phenotype
using combined small molecule inhibitors. Sensory neurons developed projections (B) and stained positively for neurofilament using
immunocytochemistry (C). Scale bar, 200 M. D, During the differentiation method, RNA was extracted from cells at different time points:
pluripotent stem cells (d 7, n  3), day 1 (n  4), day 3 (n  4), day 5 (n  6), day 7 (n  4), day 9 (n  3), day 11 (n  3), day 17 (n  3), and
day 21 (n  3). QPCR analysis revealed that mRNA concentrations of the pluripotency marker octamer transcription factor-4 (Oct4) declined as the
differentiation procedure progressed. The nociceptive markers TAC1, SCN9A, and SCN11A increased. E, Sensory neuron functionality was
determined by stimulating cells with 4 nM capsaicin and recording calcium flux. F, During differentiation from ES cells to mature sensory neurons,
ER mRNAs declined, whereas ER inclined. G–L, Mature sensory neurons were incubated with DMSO (vehicle), E2, DPN, or PPT, with or without
ICI, and RNA was extracted after 24h. G–I, Using QPCR TAC1 mRNAs were elevated by DPN and PPT compared to DPN  ICI and PPT  ICI. P2RX3
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Figure 2H;P .05), respectively.TAC1was also elevated
by PPT compared with PPT  ICI (Figure 2G; P  .01).
Although SCN9A increased with DPN (P .05), this was
not blocked by the addition of ICI (Figure 2I), and the
expression of SCN11A (Figure 2J) and TRPA1 (Figure
2K) did not appear to be ER dependent. In contrast,
TRPV1 mRNA concentrations were elevated by both E2
(P .05) andDPN (Figure 2I;P .01), and this effectwas
abrogated by ICI.
Discussion
Webelieve this is the first study to detect differences in the
expression of mRNAs encoded by the ion channels
TRPA1,P2RX3,SCN9A, andSCN11A in theperitoneum
and lesions of women suffering from CPP, some of whom
had endometriosis. We believe these insights may be in-
dicative of sensitization of nerves present within the peri-
toneal lining of women with pain and therefore shed new
light on the mechanisms responsible for development of
chronic hypersensitivity.
In women with active endometriosis, we discovered
that the concentrations of mRNAs encoded by SCN11A,
TRPA1, andTRPV1were all significantly increased in the
samplesofperitoneum.Webelieve thesenovel findings are
consistent with nociceptive changes taking place within
the peritoneum of women with endometriosis, suggesting
an increased sensitization of the peritoneum adjacent to
the lesion. We detected significant increases in TRPV1
mRNAs in both the peritoneumand in lesions, confirming
and extending a previous study (11). Notably, P2RX3
mRNAs were significantly elevated in the peritoneum of
women with CPP, regardless of whether they had active
endometriosis andwouldbe consistentwith aneuropathic
component to idiopathic CPP.
To date, researchers have used rat or chick dorsal root
ganglia (DRG) neurons as an in vitro model to investigate
the function of sensory neurons. However, because DRG
neurons represent a mixed population of somatosensory
neurons, the development of a differentiation protocol al-
lowing the generation of a population of human sensory
neurons with a nociceptor-like phenotype (15) is partic-
ularly welcome. In the current study, we detected expres-
sion of estrogen receptor mRNAs in our ES cell-derived
cultures. Treatment of cells with E2 or the ER agonist
DPN induced a significant increase in TRPV1 mRNAs
that was blocked by the addition of the ER antagonist ICI.
In addition, P2RX3, SCN9A, andTAC1mRNAswere all
increasedwhen cells were incubatedwith the ER agonist
DPN, and TAC1 was also increased by PPT. We have
previously demonstratedDPN-dependent changes in gene
expression in endometrial endothelial cells and have
shown that these were mediated via specificity protein-1
tethered transcription (16). Bioinformatics revealed the
presence of specificity protein-1 transcription factor bind-
ing sites in the promoter regions of TRPV1, P2RX3,
SCN9A, and TAC1 (Match; Biobase international.com).
TRPV1mRNAwas the only transcript that was increased
in response to E2 treatment and abrogated by the anties-
trogen ICI. Notably, bioinformatics detected several es-
trogen response elements in the promoter region of
TRPV1 and throughout the length of the transcript
(Dragon estrogen response element locator version 6.0;
National Institute of Health) that could facilitate direct
binding of E2-activated ER receptor dimers. Further stud-
ies are required to validate these findings.
Estrogens are reported to have both pro- and antino-
ciceptive properties. Mice exhibit hyperalgesia when es-
trogens are depleted after ovariectomy (17), and nocice-
ptive responses are lower inERknockoutmiceduring the
early stages of inflammation (18). The results of our study
suggest estrogensmay have a direct impact on nociception
byup-regulating the expressionof ion channels andwould
beconsistentwith reports that the expressionofTrpv1and
P2x3 proteins are decreased in DRGs frommice with tar-
geted deletions of Esr2 and Esr2 (19).
In summary, the results of this study indicate that ther-
apies targeting P2RX3 may be useful in treating CPP in
womenwith a diverse range of painful etiologies, whereas
women with active endometriosis could benefit from treat-
ments targeting TRPV1, TRPA1, SCN9A, or SCN11A.
Studies using sensory neurons suggest regulation of TRPV1
byestrogensmayprovideanexplanation for the reduction in
pain experienced when ovarian steroids are suppressed and
an opportunity for development of novel therapies.
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